CClinicalTrials.gg
Status unknownNCT03466359IDEFIXUpdated Mar 15, 2018

Energy Intake and Energy Deficit in Obese Adolescents

An interventional study of DEF-EI : Energy restriction induced energy deficit and DEF-EX : Exercise induced energy deficit in Pediatric Obesity, sponsored by University Hospital, Clermont-Ferrand. Status unknown at 1 site in France. Open to participants aged 12 Years to 16 Years. Per ClinicalTrials.gov, last updated 2018-03-15.

Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
12 Years to 16 Years
Sex
All
01

Study summary

The aim of the present study is to compare the effect of two weight loss interventions inducing the same energy deficit but one based on exercise and one using dietary restriction, on appetite control in obese adolescents. Investigator hypothesis that daily energy intake and hunger will be increased in the dietary restriction group but not in response to the exercise program.

Read the detailed description

The present study will compare the nutritional responses to two 4-month weight loss programs inducing the same energy deficit in obese adolescents, one based on exercise and the other one using dietary restriction. After a first 4-month phase stabilizing the adolescents' daily energy intake and expenditure, half of the sample with increase their physical activity to induce a 10% increase of their daily energy expenditure (maintaining the same energy intake) while the other half will stick with the same physical activity program but reduce their daily intake to match for the same 10% energy deficit. Before, at the end and 4 months after the intervention, Investigator will assess the adolescents' energy intake and appetite control by measuring: ad libitum energy intake, appetite feelings throughout the day, food preferences, food reward. But also all the potential underneath mechanisms based on gastro-peptides and adipokines. Finally, sleep metabolism will be assessed using polysomnography as a potential link between weight loss and appetite control. Body composition, quality of life, aerobic capacities and resting metabolic rate will also be measured at each time point.

02

Conditions studied

  • Pediatric Obesity

Browse trials for

Keywords

  • appetite control
  • obesity
  • Adolescents
  • Physical activity
03

Who can participate

Ages eligible
12 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • BMI percentile > 97th percentile according to the french curves.
  • ages 12-16 years old
  • Signed consent form
  • being registered in the national social security system
  • no contraindication to physical activity

Exclusion criteria

Exclusion Criteria:

  • Previous surgical interventions that is considered as non-compatible with the study.
  • Diabetes
  • weight loss during the last 6 months
  • cardiovascular disease or risks
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    DEF-EI

    these adolescents will follow a dietary restriction of 10% of their daily energy intake.

    Behavioral: DEF-EI : Energy restriction induced energy deficit

  • Experimental
    DEF-EX

    these adolescents will increase their physical activity-induced energy expenditure by 10% per day.

    Behavioral: DEF-EX : Exercise induced energy deficit

Interventions

  • BehavioralDEF-EI : Energy restriction induced energy deficit

    DEF-EI : Energy restriction induced energy deficit The content of their energy intake will be decreased by 10% daily compared with the phase one of the protocol (stabilization of intake). This decrease will be allowed by the internship nature of the clinical program; all the meals are prepared and served by the personal of the clinical centre.

  • BehavioralDEF-EX : Exercise induced energy deficit

    DEF-EX : Exercise induced energy deficit While their intake will remain the same as phase 1, they will increase their physical activity energy expenditure by 10% thanks to an increase of their prescribed exercise intensities or durations.

05

What researchers measure

Primary outcomes

  1. Changes in energy intake at lunch time

    food intake will be measured ad libitum during a lunch time buffet. The adolescents will be offered an ad libitum buffet-type meal composed based on their food intake preferences. Their intake will be assessed by a member of the investigation team

    Time frame: Before, after 10 months and 4 month after the intervention

Secondary outcomes

  1. change in FM

    Fat mass (FM) was assessed using DXA following standardized procedures

    Time frame: Before, after 10 months and 4 month after the intervention

  2. Aerobic capacity

    VO2peak will be measured during a graded exhaustive cycling test performed by a specialized medical investigator from the Department of Sports Medicine, Functional and Respiratory Rehabilitation (Clermont-Ferrand University Hospital). The initial power will be set at 30 W for three minutes and followed by 15 W increments every 1.5 minutes.

    Time frame: Before, after 10 months and 4 month after the intervention

  3. Insulin concentration

    : Insulin will be assessed thanks to a fasting blood sample taken by a specialized nurse.

    Time frame: Before, after 10 months and 4 month after the intervention

  4. Glycaemia concentration

    glycaemia, will be assessed thanks to a fasting blood sample taken by a specialized nurse.

    Time frame: Before, after 10 months and 4 month after the intervention

  5. total cholesterol concentration

    cholesterol total will be assessed thanks to a fasting blood sample taken by a specialized nurse.

    Time frame: Before, after 10 months and 4 month after the intervention.

  6. HDL-C concentration

    HDL-C will be assessed thanks to a fasting blood sample taken by a specialized nurse

    Time frame: Before, after 10 months and 4 month after the intervention

  7. LDL-C concentration

    LDL-C will be assessed thanks to a fasting blood sample taken by a specialized nurse.

    Time frame: Before, after 10 months and 4 month after the intervention

  8. Triglycerides concentration

    Triglycerides concentration will be assessed thanks to a fasting blood sample taken by a specialized nurse.

    Time frame: Before, after 10 months and 4 month after the intervention

  9. Acylated Ghrelin concentration

    Acylated Ghrelin concentration will be assessed thanks to a fasting blood sample taken by a specialized nurse

    Time frame: Before, after 10 months and 4 month after the intervention

  10. Leptin concentration

    Leptin concentration will be assessed thanks to a fasting blood sample taken by a specialized nurse

    Time frame: Before, after 10 months and 4 month after the intervention

  11. Sleep metabolism

    sleep duration will be assessed during an overnight polysomnography.

    Time frame: Before, after 10 months and 4 month after the intervention

  12. appetite feelings

    hunger satiety will be assessed using visual analogue scale at regular interval through a test day

    Time frame: Before, after 10 months and 4 month after the intervention

  13. Quality of life Score

    A total Quality of life score will be obtain thanks to the "SF36" questionnaire. This is a self-reported questionnaire. A member of the investigation team will be present to help and guide the adolescents if needed

    Time frame: Before, after 10 months and 4 month after the intervention

  14. Health Perception

    A total Health Perception score will be obtain thanks to the "Health Perception Questionnaire ". This is a self-reported questionnaire. A member of the investigation team will be present to help and guide the adolescents if needed.

    Time frame: Before, after 10 months and 4 month after the intervention

06

Study locations

1 of 1 sites recruiting
  • CHU Clermont-Ferrand
    Clermont-Ferrand, 63003, France
    Recruiting
07

References and documents

Publications

  • Roche J, Corgosinho FC, Damaso AR, Isacco L, Miguet M, Fillon A, Guyon A, Moreira GA, Pradella-Hallinan M, Tufik S, Tulio de Mello M, Gillet V, Pereira B, Duclos M, Boirie Y, Masurier J, Franco P, Thivel D, Mougin F. Sleep-disordered breathing in adolescents with obesity: When does it start to affect cardiometabolic health? Nutr Metab Cardiovasc Dis. 2020 Apr 12;30(4):683-693. doi: 10.1016/j.numecd.2019.12.003. Epub 2019 Dec 16. PubMed 32008915 ↗
08

Registry details

Key details

Study ID
NCT03466359
Lead sponsor
University Hospital, Clermont-Ferrand
Collaborators
Tza Nou - Maison médicale pour enfants et adolescentes - 230, rue Vercingétorix - B.P. 77 - 63150 La Bourboule, SSR Nutrition-Obésité - 33-35 rue Maréchal Leclerc - 63000 Clermont-Ferrand, Laboratoire AME2P. Campus universitaire des cezeaux, 63170 Aubiere, Cedex
Responsible party
Sponsor
First posted
Mar 15, 2018
Start date
Jan 8, 2018
Primary completion
Dec 2018 (estimated)
Completion
Dec 2018 (estimated)
Last update
Mar 15, 2018

Study contacts

Patrick LACARIN
Contact
placarin@chu-clermontferrand.fr
04 73 75 11 95
Yves BOIRIE
principal investigator · University Hospital, Clermont-Ferrand

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion